Your browser doesn't support javascript.
loading
Measuring the subcellular compartmentalization of viral infections by protein complementation assay.
Fernandez, Juliette; Hassen-Khodja, Cédric; Georget, Virginie; Rose, Thierry; Jacob, Yves; Janin, Yves L; Nisole, Sébastien; Vidalain, Pierre-Olivier; Arhel, Nathalie J.
Affiliation
  • Fernandez J; Institut de Recherche en Infectiologie de Montpellier, CNRS, UMR 9004 Université de Montpellier, 34090 Montpellier, France.
  • Hassen-Khodja C; Montpellier Ressources Imagerie, BioCampus Montpellier, CNRS, INSERM, Université de Montpellier, 34090 Montpellier, France.
  • Georget V; Montpellier Ressources Imagerie, BioCampus Montpellier, CNRS, INSERM, Université de Montpellier, 34090 Montpellier, France.
  • Rose T; Unité de Biologie Cellulaire des Lymphocytes, Institut Pasteur, INSERM 1221, 75015 Paris, France.
  • Jacob Y; Unité de Génétique Moléculaire des Virus à Acide Ribonucléique, Institut Pasteur, CNRS UMR 3569, 75015 Paris, France.
  • Janin YL; Unité de Chimie et Biocatalyse, Institut Pasteur, CNRS UMR 3523, 75724 Paris, France.
  • Nisole S; Institut de Recherche en Infectiologie de Montpellier, CNRS, UMR 9004 Université de Montpellier, 34090 Montpellier, France.
  • Vidalain PO; Centre International de Recherche en Infectiologie, Université de Lyon, INSERM U1111, Université Claude Bernard Lyon 1, CNRS UMR 5308, École Normale Supérieure de Lyon, 69342 Lyon, France.
  • Arhel NJ; Equipe Chimie et Biologie, Modélisation et Immunologie pour la Thérapie, Université Paris Descartes, CNRS UMR 8601, 75006 Paris, France.
Proc Natl Acad Sci U S A ; 118(2)2021 01 12.
Article in En | MEDLINE | ID: mdl-33402530
ABSTRACT
The recent emergence and reemergence of viruses in the human population has highlighted the need to develop broader panels of therapeutic molecules. High-throughput screening assays opening access to untargeted steps of the viral replication cycle will provide powerful leverage to identify innovative antiviral molecules. We report here the development of an innovative protein complementation assay, termed αCentauri, to measure viral translocation between subcellular compartments. As a proof of concept, the Centauri fragment was either tethered to the nuclear pore complex or sequestered in the nucleus, while the complementary α fragment (<16 amino acids) was attached to the integrase proteins of infectious HIV-1. The translocation of viral ribonucleoproteins from the cytoplasm to the nuclear envelope or to the nucleoplasm efficiently reconstituted superfolder green fluorescent protein or NanoLuc αCentauri reporters. These fluorescence- or bioluminescence-based assays offer a robust readout of specific steps of viral infection in a multiwell format that is compatible for high-throughput screening and is validated by a short hairpin RNA-based prototype screen.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Virus Diseases / High-Throughput Screening Assays Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Virus Diseases / High-Throughput Screening Assays Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2021 Document type: Article Affiliation country:
...